Katarzyna M. S.
- Country
- Poland
- Department
- Klinika Kardiologii
Research Overview
- Efficacy and Safety of IKT-001 in Adults with WHO Group 1 Pulmonary Arterial Hypertension: An Adaptive, Randomized, Double-Blind, Placebo-Controlled Trial
- IV Ferric Carboxymaltose vs Oral Ferrous Sulfate on Physical Performance, QoL, and Cognition in Frail Elderly with Iron Deficiency and CVD: Randomized Controlled Trial
- Long-term Safety Evaluation of Tadalafil and Macitentan in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Data & Insights
Has run more than one trial at 107 of 613 partner sites.
Specializations
Coronary artery disease and acute coronary syndromes
Clinical research includes treatment strategies for acute myocardial infarction, acute coronary syndrome, and coronary revascularization, with a strong focus on antithrombotic management in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting.
- Antiplatelet therapy optimization
- Anticoagulation in atrial fibrillation with PCI
- Lipid-lowering therapy after acute coronary events
Additional interest extends to prevention of recurrent ischemic events and management of bleeding risk in complex cardiovascular patients.
Heart failure and cardiomyopathy
The investigator is involved in studies addressing chronic heart failure, worsening heart failure, heart failure with preserved ejection fraction, and non-ischemic cardiomyopathy, including inflammatory and fibrotic cardiac disease.
- Myocarditis and inflammatory cardiomyopathy
- Takotsubo syndrome
- Arrhythmogenic cardiomyopathy
Therapeutic interest also covers myocardial recovery, remodeling, and symptom control in advanced cardiac dysfunction.
Thromboembolic disease and stroke prevention
Research activity includes prevention and treatment of acute ischemic stroke, high-risk transient ischemic attack, and stroke risk in patients with atrial fibrillation, particularly in the setting of structural and interventional cardiology.
- Secondary stroke prevention
- Periprocedural anticoagulant therapy
- Left atrial appendage closure
Additional involvement includes balancing thrombotic and bleeding outcomes in patients with complex cardiovascular comorbidity.
Pulmonary vascular and interstitial lung disease
The clinical portfolio includes pulmonary arterial hypertension, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, progressive fibrosing interstitial lung disease, and scleroderma-associated interstitial lung disease.
- Fibrotic lung disease
- Pulmonary hypertension
- Severe eosinophilic asthma
Therapeutic interest also extends to chronic respiratory impairment and anti-fibrotic treatment approaches.
Inflammatory and systemic immune-mediated disorders
Research involvement also covers selected autoimmune and inflammatory diseases, including systemic lupus erythematosus, myasthenia gravis, and Fabry disease with cardiac involvement.
- Immune-mediated neuromuscular disease
- Systemic inflammatory disease
- Cardiac involvement in metabolic disease
Clinical interests include modulation of inflammation and organ-specific complications affecting the heart and lungs.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.